Tolerability of risedronate in postmenopausal women intolerant of alendronate
Jonathan Derrick Adachi, S. Adámi, P. D. Miller, Wojciech P. Olszynski, David L. Kendler, Stuart L. Silverman, Anna Licata, Z. Li, Edda L. Gomez-Panzani
Abstract
Jonathan Derrick Adachi, S. Adámi, P. D. Miller, Wojciech P. Olszynski, David L. Kendler, Stuart L. Silverman, Anna Licata, Z. Li, Edda L. Gomez-Panzani
Abstract
An abstract is not available in the OpenAlex record for this paper.
OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Key concepts: Tolerability, Etidronic acid, Medicine, Postmenopausal women, Alendronic acid, Internal medicine, Osteoporosis, Bisphosphonate